Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2018

Mar 20, 2018

29821_dirs_2018-03-20_c8eb7145-6db0-4644-a376-5b089553cdc6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-03-19

Reporting Person: Brennan Daniel J. (EVP and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-03-19 Common Stock M 20461.0000 $7.4100 Acquired 299644.0000 Direct
2018-03-19 Common Stock M 13661.0000 $13.0800 Acquired 313305.0000 Direct
2018-03-19 Common Stock M 12422.0000 $7.1600 Acquired 325727.0000 Direct
2018-03-19 Common Stock M 7572.0000 $7.3900 Acquired 333299.0000 Direct
2018-03-19 Common Stock M 6093.0000 $6.2800 Acquired 339392.0000 Direct
2018-03-19 Common Stock S 60209.0000 $27.8698 Disposed 279183.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-03-19 Stock Option (Right to Buy) $7.4100 M 20461.0000 Disposed 2020-02-16 Common Stock (20461.0000) Direct
2018-03-19 Stock Option (Right to Buy) $13.0800 M 13661.0000 Disposed 2024-02-24 Common Stock (13661.0000) Direct
2018-03-19 Stock Option (Right to Buy) $6.2800 M 6093.0000 Disposed 2022-02-27 Common Stock (6093.0000) Direct
2018-03-19 Stock Option (Right to Buy) $7.1600 M 12422.0000 Disposed 2021-02-28 Common Stock (12422.0000) Direct
2018-03-19 Stock Option (Right to Buy) $7.3900 M 7572.0000 Disposed 2023-02-28 Common Stock (7572.0000) Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $27.68 to $28.02, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F3: Grant to the reporting person of an option to purchase a specified number of common stock vesting in four equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.

F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

F5: Grant to the reporting person of an option to purchase a specified number of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.

F6: Grant to the reporting person of an option to purchase a specified number of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.

F7: Grant to the reporting person of an option to purchase a specified number of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.